Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nik Krajnc

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
The Journal of Headache and Pain|September 5, 2024
Therapeutic effect of a single lumbar puncture in idiopathic intracranial hypertensionSina Zaic, Nik Krajnc, Stefan Macher, et al.
The Journal of Headache and Pain|August 1, 2024
An interdisciplinary integrated specialized one-stop outpatient clinic for idiopathic intracranial hypertension - a comprehensive assessment of patient satisfactionGabriel Bsteh, Stefan Macher, Nik Krajnc, et al.
The Journal of Headache and Pain|May 6, 2024
The additive value of complementing diagnostic idiopathic intracranial hypertension criteria by MRI - an external validation studyStefan Macher, Wolfgang Marik, Nik Krajnc, et al.
The Journal of Headache and Pain|May 7, 2024
An interdisciplinary integrated specialized one-stop outpatient clinic for idiopathic intracranial hypertension - an assessment of sick leave, presenteeism, and health care utilizationGabriel Bsteh, Stefan Macher, Nik Krajnc, et al.
Frontiers in Neurology|July 22, 2022
Peripheral Hemolysis in Relation to Iron Rim Presence and Brain Volume in Multiple SclerosisNik Krajnc, Gabriel Bsteh, Gregor Kasprian, et al.
Multiple Sclerosis and Related Disorders|April 27, 2022
Alemtuzumab induced hemodynamic change in relapsing multiple sclerosis occurs independent of corticosteroid premedication - a retrospective multicentre studyFranziska Di Pauli, Katharina Riedl, Harald Hegen, et al.
Multiple Sclerosis and Related Disorders|March 13, 2024
Olfactory threshold as a biomarker of long-term relapse activity in multiple sclerosisKlaus Berek, Harald Hegen, Michael Auer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 18, 2023
Odour discrimination and identification as a biomarker of long-term disability worsening in multiple sclerosisKlaus Berek, Harald Hegen, Michael Auer, et al.
Digital Health|November 10, 2022
Feasibility of a smartphone app to monitor patient reported outcomes in multiple sclerosis: The haMSter interventional trialPatrick Altmann, Markus Ponleitner, Tobias Monschein, et al.
European Journal of Neurology|December 17, 2025
The Value of Oligoclonal Bands in Multiple Sclerosis Compared to Other Neurological Disorders: A Retrospective Data Analysis From an Austrian Tertiary CenterTobias Monschein, Benjamin Scheicher, Markus Ponleitner, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
The Journal of Headache and Pain|September 5, 2024
Therapeutic effect of a single lumbar puncture in idiopathic intracranial hypertensionSina Zaic, Nik Krajnc, Stefan Macher, et al.
The Journal of Headache and Pain|August 1, 2024
An interdisciplinary integrated specialized one-stop outpatient clinic for idiopathic intracranial hypertension - a comprehensive assessment of patient satisfactionGabriel Bsteh, Stefan Macher, Nik Krajnc, et al.
The Journal of Headache and Pain|May 6, 2024
The additive value of complementing diagnostic idiopathic intracranial hypertension criteria by MRI - an external validation studyStefan Macher, Wolfgang Marik, Nik Krajnc, et al.
The Journal of Headache and Pain|May 7, 2024
An interdisciplinary integrated specialized one-stop outpatient clinic for idiopathic intracranial hypertension - an assessment of sick leave, presenteeism, and health care utilizationGabriel Bsteh, Stefan Macher, Nik Krajnc, et al.
Frontiers in Neurology|July 22, 2022
Peripheral Hemolysis in Relation to Iron Rim Presence and Brain Volume in Multiple SclerosisNik Krajnc, Gabriel Bsteh, Gregor Kasprian, et al.
Multiple Sclerosis and Related Disorders|April 27, 2022
Alemtuzumab induced hemodynamic change in relapsing multiple sclerosis occurs independent of corticosteroid premedication - a retrospective multicentre studyFranziska Di Pauli, Katharina Riedl, Harald Hegen, et al.
Multiple Sclerosis and Related Disorders|March 13, 2024
Olfactory threshold as a biomarker of long-term relapse activity in multiple sclerosisKlaus Berek, Harald Hegen, Michael Auer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 18, 2023
Odour discrimination and identification as a biomarker of long-term disability worsening in multiple sclerosisKlaus Berek, Harald Hegen, Michael Auer, et al.
Digital Health|November 10, 2022
Feasibility of a smartphone app to monitor patient reported outcomes in multiple sclerosis: The haMSter interventional trialPatrick Altmann, Markus Ponleitner, Tobias Monschein, et al.
European Journal of Neurology|December 17, 2025
The Value of Oligoclonal Bands in Multiple Sclerosis Compared to Other Neurological Disorders: A Retrospective Data Analysis From an Austrian Tertiary CenterTobias Monschein, Benjamin Scheicher, Markus Ponleitner, et al.
Pageof 7